Têxtil Renauxview S.A. (TXRX4.SA)
BRL 2.1
(0.0%)
BRL 2.1
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 85.48 Million | -3.39 Million | 3.88 Million | -753 Thousand | 3.71 Million | 3.73 Million |
| Net Income | 16.74 Million | 1.12 Million | -21.79 Million | -17.9 Million | 21.4 Million | -11.44 Million |
| Depreciation & Amortization | 5.02 Million | 4.95 Million | 4.94 Million | 5.8 Million | 4.91 Million | 5.23 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 45.26 Million | -35.36 Million | -25.02 Million | -14.88 Million | -19.03 Million | 1.71 Million |
| Other non-cash items | 18.44 Million | 25.88 Million | 45.75 Million | 26.23 Million | -3.58 Million | 13.45 Million |
| Investing Cash Flow | 2.32 Million | -4.81 Million | -2.48 Million | -913 Thousand | -5.39 Million | -1.03 Million |
| Investments in PPE | -30 Thousand | -209 Thousand | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 2.35 Million | -4.6 Million | -2.48 Million | -913 Thousand | -5.39 Million | -1.03 Million |
| Financing Cash Flow | -87.55 Million | 8.15 Million | -1.34 Million | 1.43 Million | 1.22 Million | -1.92 Million |
| Debt repayment | -74.27 Million | -81.28 Million | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -56.06 Million | 8.15 Million | -1.34 Million | 1.43 Million | 1.22 Million | -1.92 Million |
| Accounts receivables | 24.71 Million | -18.36 Million | - | - | - | - |
| Accounts payables | -24.71 Million | 18.36 Million | - | - | - | - |
| Inventory | 27.34 Million | -24.65 Million | - | - | - | - |
| Other working capital | 17.91 Million | -10.7 Million | -25.02 Million | -14.88 Million | -19.03 Million | 1.71 Million |
| Cash at beginning of period | 178 Thousand | 236 Thousand | 169 Thousand | 403 Thousand | 861 Thousand | 88 Thousand |
| Cash at end of period | 424 Thousand | 178 Thousand | 236 Thousand | 169 Thousand | 403 Thousand | 861 Thousand |
| Capital Expenditure | -30 Thousand | -209 Thousand | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 246 Thousand | -58 Thousand | 67 Thousand | -234 Thousand | -458 Thousand | 773 Thousand |
| Free Cash Flow | 85.45 Million | -3.6 Million | 3.88 Million | -753 Thousand | 3.71 Million | 3.73 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.73 Million | -14.3 Million | 45.74 Million | 16.74 Million | -14.15 Million | -12.1 Million |
| Depreciation & Amortization | 1.05 Million | 1.08 Million | 1.65 Million | 5.02 Million | 1.24 Million | 856 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -5.6 Million | 10.36 Million | 11.53 Million | 45.26 Million | 12.82 Million | 12.95 Million |
| Other non-cash items | 9.21 Million | 10.96 Million | 1.97 Million | 18.44 Million | 4.57 Million | 6.61 Million |
| Investing Cash Flow | -183 Thousand | -54 Thousand | 1.98 Million | 2.32 Million | -6000.00 | 450 Thousand |
| Investments in PPE | - | - | -182 Thousand | -30 Thousand | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -183 Thousand | -54 Thousand | 2.16 Million | 2.35 Million | -6000.00 | 450 Thousand |
| Financing Cash Flow | -4.03 Million | -6.12 Million | -62.59 Million | -87.55 Million | -4.47 Million | -8.89 Million |
| Debt repayment | - | - | - | -74.27 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -4.03 Million | -6.12 Million | -62.59 Million | -56.06 Million | -4.47 Million | -8.89 Million |
| Accounts receivables | - | - | 24.71 Million | 24.71 Million | - | - |
| Accounts payables | - | - | 904 Thousand | -24.71 Million | - | - |
| Inventory | - | - | 27.34 Million | 27.34 Million | - | - |
| Other working capital | -5.6 Million | 10.36 Million | -41.43 Million | 17.91 Million | 12.82 Million | 12.95 Million |
| Cash at beginning of period | 179 Thousand | 424 Thousand | 135 Thousand | 178 Thousand | 120 Thousand | 244 Thousand |
| Cash at end of period | 258 Thousand | 179 Thousand | 424 Thousand | 424 Thousand | 135 Thousand | 120 Thousand |
| Capital Expenditure | - | - | -182 Thousand | -30 Thousand | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 79 Thousand | -245 Thousand | 289 Thousand | 246 Thousand | 15 Thousand | -124 Thousand |
| Free Cash Flow | 4.29 Million | 5.93 Million | 60.71 Million | 85.45 Million | 4.49 Million | 8.32 Million |
THOMASCOTT
DELHY
FHSEY
PNMXO
RELCHEMQ
EMAE4